• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038
• 5. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Aminopiperidines

Introduction to 4-(4-Piperidyl)morpholine Dihydrochloride (CAS No. 334942-10-8)

4-(4-Piperidyl)morpholine dihydrochloride, also known by its CAS number 334942-10-8, is a versatile compound with significant applications in the pharmaceutical and chemical industries. This compound is a salt form of 4-(4-piperidyl)morpholine, which is a key intermediate in the synthesis of various bioactive molecules and pharmaceuticals. The dihydrochloride salt form enhances its solubility and stability, making it particularly useful in both research and industrial settings.

The chemical structure of 4-(4-Piperidyl)morpholine dihydrochloride consists of a morpholine ring attached to a piperidine ring, with the entire molecule being protonated to form the dihydrochloride salt. This unique structure confers the compound with specific pharmacological properties, including potential central nervous system (CNS) activity and interactions with various receptors and enzymes.

In recent years, there has been increasing interest in the use of 4-(4-Piperidyl)morpholine dihydrochloride as a building block for the development of novel therapeutic agents. Research has shown that this compound can be used to synthesize a wide range of derivatives with diverse biological activities. For instance, studies have explored its potential as an antagonist for specific receptors, such as the serotonin 5-HT2A receptor, which is implicated in various psychiatric disorders including schizophrenia and depression.

One notable study published in the Journal of Medicinal Chemistry in 2021 investigated the use of 4-(4-Piperidyl)morpholine dihydrochloride as a scaffold for designing selective serotonin reuptake inhibitors (SSRIs). The researchers found that derivatives of this compound exhibited potent SSRI activity and demonstrated promising efficacy in preclinical models of depression. These findings highlight the potential of 4-(4-Piperidyl)morpholine dihydrochloride as a lead compound for further drug development.

Beyond its applications in psychiatric disorders, 4-(4-Piperidyl)morpholine dihydrochloride has also shown promise in other therapeutic areas. For example, research published in the European Journal of Medicinal Chemistry in 2020 explored its use as an inhibitor of protein kinases, which are key targets in cancer therapy. The study demonstrated that certain derivatives of this compound exhibited selective inhibition of specific kinases, suggesting its potential as an anticancer agent.

In addition to its therapeutic applications, 4-(4-Piperidyl)morpholine dihydrochloride is also used as a reference standard in analytical chemistry. Its well-defined structure and high purity make it an ideal candidate for calibration and validation purposes in various analytical methods. This ensures accurate and reliable results in quality control processes within pharmaceutical and chemical industries.

The synthesis of 4-(4-Piperidyl)morpholine dihydrochloride typically involves several steps, including the formation of the morpholine ring and its subsequent attachment to the piperidine ring. Various synthetic routes have been reported, each with its own advantages and limitations. One common approach involves the reaction of 1-benzyl-4-piperidone with morpholine followed by deprotection to yield the desired product. Recent advancements in synthetic chemistry have led to more efficient and environmentally friendly methods, such as those utilizing catalytic processes or microwave-assisted synthesis.

The physical properties of 4-(4-Piperidyl)morpholine dihydrochloride, including its melting point, solubility, and stability, are well-characterized and have been extensively studied. These properties are crucial for optimizing its use in various applications, from laboratory research to industrial-scale production. For instance, its high solubility in water and organic solvents makes it suitable for formulation into different dosage forms, such as tablets or injectable solutions.

In conclusion, 4-(4-Piperidyl)morpholine dihydrochloride (CAS No. 334942-10-8) is a valuable compound with a wide range of applications in pharmaceutical research and development. Its unique chemical structure and pharmacological properties make it an attractive candidate for the synthesis of novel therapeutic agents targeting various diseases. Ongoing research continues to uncover new possibilities for this compound, further solidifying its importance in the field of medicinal chemistry.

• 216985-68-1(4-(2-(Piperidin-2-yl)ethyl)morpholine)
• 898808-60-1(4-MORPHOLINEPROPANAMINE, N-METHYL-N-4-PIPERIDINYL-)
• 858453-96-0(4-(morpholin-4-yl)azepane)
• 88472-69-9(Morpholine, 4,4'-(1,3-dimethyl-1,3-propanediyl)bis-)
• 550370-31-5(4-(4-Piperidinyl)morpholine dihydrochloride)
• 36882-02-7(Morpholine, 4-(1-methyl-4-piperidinyl)-)
• 53617-35-9(4-(piperidin-4-yl)morpholine)
• 930604-28-7(4-(4-Methylpiperidin-4-yl)Morpholine dihydrochloride)
• 1032757-76-8(4-Piperidinamine, n-(2-methoxyethyl)-n-methyl-, hydrochloride (1:1))
• 1185304-40-8(3-(4-Morpholinyl)-8-azabicyclo3.2.1octane Dihydrochloride)